About this trial
The goal of this study is to evaluate quality of life (QoL) and frailty trajectories from advanced chronic kidney disease (CKD) to after dialysis initiation, specifically comparing patients choosing home dialysis and in-center hemodialysis.
The main questions it aims to answer are:
1. What is the trajectory of QoL in patients transitioning from advanced CKD to dialysis (up to 12 months after initiation) and how does these changes differ for patients oriented towards home dialysis and in-center hemodialysis? 2. Is the development of frailty after dialysis initiation less likely in patient pursuing home dialysis? 3. What is the variation in other PROMs and health outcomes (fatigue, anxiety \& depression, general assessment, cognitive function) form advanced CKD to the first 12 months after dialysis initiation? 4. What are the predictors of severe decline in QoL, frailty and other important health outcomes (fatigue, cognition, anxiety \& depression) during CKD G5 follow-up and after 12 months post dialysis initiation?
Participants will be ask to:
* Answer some questions and complete questionnaires each 3 months; * Do a a grip test and a walking test each 6 months to evaluate their frailty;
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients followed in advanced CKD clinic;
eGFR ≤12 mL/min/1.73m2 96;
Understand English or French.
Disqualifiers
Orientation toward conservative treatment;
Planned kidney transplantation < 6 months;
Unable to provide consent due to severe cognitive or psychiatric disease;
Previous treatment with dialysis > 3 month;
Trial population
Adults followed in advanced chronic kidney disease clinics recruited from 7 centers across Canada
Trial design
Cohort
Prospective
Treatments tested in this trial
Home dialysis or In-Center dialysis
Other interventionInitiation of dialysis with home dialysis (peritoneal dialysis or home hemodialysis) or in-center dialysis (hemodialysis)
Treatment groups
Trial outcomes
Primary outcomes
Change in Kidney Disease Quality of Life - 36
Patients Scale from 0-100 (0 = poor, 100 = excellent).
Secondary outcomes
Change in Fried Frailty phenotype
5 components (slowness, weakness, weight loss, low physical activity, exhaustion) with classification as no-frail, pre-frail or frail.
Change in Clinical Frailty Scale
Scale 1 (very fit) to 9 (terminally ill)
Change in Hospital Anxiety and Depression
14 items scale (7 anxiety, 7 depression) with score \>8 as cut-off for increased risk of depression and anxiety.
Change in Fatigue
3 items questionnaire to assess fatigue and energy.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ciusss de L'Est de l'Île de Montréal
Lead sponsor
The Kidney Foundation of Canada
Collaborator